Williams KA, Magnuson M, Majeed W, LaConte SM, Peltier SJ, Hu X, et al
This reveals a new mechanism by which GLP-1R agonism counters obesity, and provides us with new insights into novel therapeutic targets to treat obesity and its associated metabolic disorders
Retrieved from Portillo Canales, S
The honest summary is that weight loss reduces inflammation
Muscle Loss If appetite suppression is too high, protein and nutrient intake decreases, leading to: Muscle loss Increased fatigue Reduced metabolic rate Slower recovery after surgery Strength training and sufficient protein (1.2g per kg of body weight) are essential
Safety concerns Using improperly stored semaglutide can create safety risks: The medication may cause unexpected side effects Bacterial growth could occur in compromised solutions Chemical changes might produce harmful byproducts How can you tell if semaglutide has gone bad